Hearing of the Senate Health, Education, Labor and Pension Committee - Opening Statement of Sen. Murray, Hearing on The Opioid Crisis: The Role of Technology and Data in Preventing and Treating Addiction

Hearing

Date: Feb. 27, 2018
Location: Washington, DC
Issues: Drugs

"Thank you Mr. Chairman.

"Last week when I was back in Washington state, I heard firsthand from families and communities facing this epidemic.

"I heard from a young man who ended up in foster care as his parents struggled with drug use and mental health issues. I heard from a mother who felt helpless as her son experienced addiction, sought help, struggled with relapse, and tragically died of an opioid overdose. I heard from another parent whose children were taken away before she was able to overcome her addiction. I heard from an elementary school principal whose students should be learning to read, and write, and do arithmetic, should be running around full of energy and excitement, but are instead struggling to focus at school because of the trauma of their parents' addiction at home. On a previous trip to a hospital in Longview, Washington, I heard how half of the babies there were born to mothers addicted to opioids.

"And just as I've been listening to voices back in Washington state, this committee has also been listening here in Washington, D.C., and learning more about what our communities need to fight this national epidemic. I'm grateful to our witnesses today for adding their voices to that discussion. Technology and data offer important opportunities to address the opioid crisis, prevent addiction, and avoid the tragedies so many families are facing.

"While we can see the promise of this approach through efforts such as prescription drug monitoring programs, or PDMPs, which almost every state has established--there is much more we can do. These electronic databases, which keep track of prescriptions for controlled substances, can be a great resource to fight opioid misuse.

"However, "big data" by itself doesn't guarantee a big impact. We need to use the data creatively--protecting the privacy of patients, while finding innovative ways to protect their safety and health.

"Some states are pioneering ways to make this happen. For example, some states require doctors to check the database so they are aware of a patient's existing prescriptions before they write new ones. States that require this saw a drop in opioid prescriptions, drug-related hospitalizations, and overdose deaths.

"Others have built-in systems to alert doctors of alarming patterns or signs that a patient may be at risk of drug misuse, and others have made PDMPs easier to access and use by integrating them with electronic health records.

"Still, while many states are looking at new ways to put their data to good use, there is also important data many still can't use--the data collected by neighboring states. Too many of the PDMP systems are not sufficiently interoperable. That means they aren't sharing data and working effectively with each other. As a result, the prescription a patient receives in one state may not show up in the system of another state. Two doctors in different states may not see they are writing prescriptions for the same patient. They may not have the data to see a pattern of substance misuse or to prevent one from developing. We need more states to move toward an interoperable PDMP system so that we can put the pieces together and give doctors a full picture of a patient's prescription history.

"And it isn't just states that must understand the role that technology and data can play in addressing this epidemic. Pharmacies, prescribers, patients and all stakeholders must take a look at how new advances can help prevent and address opioid misuse. Whether through more responsible prescribing based on risk factors, safe disposal of controlled substances, or safety checks by pharmacists upon dispensing.

"And we must always be mindful of the importance of patient privacy. Data must be easy to use--but hard to misuse.

"People dealing with addiction already face stigma, and may fear speaking out or seeking help. We must ensure that our data practices and protocols don't create new risks or fears that patients' most private battles might be made public against their wishes. Striking that balance is no easy task, but it is an important one.

"We've made great progress so far in striking difficult balances and responding to this crisis with bipartisan solutions. I'm hopeful that, through conversations like this one, we can continue that bipartisan progress as we look at how technology can empower partners fighting this crisis at every level from federal, state and local government, to health care providers, to educators, to public safety officials, to families like those I met with in Washington state.

"I look forward to hearing from our witnesses and learning more from their experience and expertise.

"And Mr. Chairman, I very much look forward to our continued work together--and with so many other Senators--to find and move forward key legislative solutions to the many challenges we face in fighting this crisis.

"Thank you."


Source
arrow_upward